Brighter signs 5-year agreement and receives initial order for Actiste® worth EUR 1.2 Million in Ghana
Brighter AB (publ) (“The company” or “Brighter”) has signed a five-year distribution agreement with Fretac Plus Ventures in Ghana (“the Distributor'') regarding Brighter’s pioneering product portfolio for diabetes management, Actiste® (“Actiste® Service”). Both Actiste® and the newly developed Actiste® Mini are included in the agreement. The agreed minimum order volume for the first 12 months of the five-year agreement amounts to 4,000 subscriptions (24 months), corresponding to an estimated revenue of c. EUR 3.1 million. The exact amount depends on the final distribution between